The team expects to get regulatory approval for the tentatively named Active Engagement Fund by May and seeks to raise and invest $1 bn in 3 years
While Tata's retail strategy, experts said, is unlikely to change overnight, the group is still looking to grow its footprint, albeit carefully
Bombay House needs to take a hard look at its strategy
TCS remains the cash cow for the group, accounting for 70% of the group's market capitalisation and over 90% of holding company Tata Sons' dividend income from all group companies
Mukund Rajan will be chairman; Quantum's Ajit Dayal to lead fund
The Tata group has seen an impressive increase in brand value in 2019
Four of the top five were from TCS in FY18
With trade wars and protectionism, companies would have to become more agile
In his address, Chandra goaded the chief executives of all the group companies from India and abroad to set higher goals and take the group to a newer height.
R Gopalakrishnan, a former Director of Tata Sons Ltd, imagines a conversation among Founder Jamsetji, his son, Dorabji, his successor, Nowroji Saklatwala, and his successor, JRD Tata
The hikes in remuneration were in line with the companies' performance, barring TCS which had flat growth in profit
Evaluating proposal to combine foods, beverages, add dairy
While Tata Motors' domestic business contributed with a 33 per cent year-on-year jump in net sales last financial year, the story at JLR was disappointing
IT major nears $100 bn m-cap, accounts for 61% of the group's combined valuation
Asks CEOs of group companies to come up with concrete plans to drive 3S philosophy
A possible US-EU trade war could hurt Tata firms as the US and Europe account for 45% of the group's auto, steel, chemical, and beverage business
The financial details of the mandate were not disclosed
Corporate governance lapses in Tata Sons and Tata Trusts are not being rectified: Nirmalya Kumar
The group is clear it would do its best to retain the iconic Taj Mansingh in New Delhi, which is coming up for auction soon
Advinus Therapeutics was established by the Tata group in 2005